Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Chinese Drugmakers Gain After Reports of Tick Deaths, Superbug

Sept. 9 (Bloomberg) -- Chinese drugmakers rose to the highest in four months after Xinhua News reported deaths in China’s central Henan province from tick-borne disease and a Health Ministry alert against a drug-resistant bacteria.

Shandong Lukang Pharmaceutical Co., a Chinese antibiotic maker, jumped by the 10 percent daily limit in Shanghai as of 10:01 a.m. local time. North China Pharmaceutical Co. climbed 5.2 percent to 11.18 yuan, the biggest increase since May 27.

A measure of healthcare-related stocks had the biggest gain among the 10 industry groups on the CSI 300 Index and rose to the highest since April 27. The benchmark Shanghai Composite Index slid 0.4 percent to 2,685.48.

“The tick deaths certainly provided a trigger for today’s gains in healthcare stocks, which may benefit from increased demand,” said Liu Bin, Shanghai-based analyst at Guoyuan Securities Co., in a phone interview.

Link to Company News:{002007 CH <Equity> CN <GO>} Link to Company News:{600789 CH <Equity> CN <GO>} Link to Company News:{600812 CH <Equity> CN <GO>}

To contact the reporter on this story: Chua Kong Ho in Shanghai at kchua6@bloomberg.net

To contact the editor responsible for this story: Reinie Booysen at rbooysen@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.